Pliant Therapeutics Inc.

Pliant Therapeutics Inc.

World Rank (Jan-05-2024)
8,026
Market Cap (Jan-05-2024)
1.119 Billion USD
World Rank (Jul-30-2023)
8,672
Market Cap (Jul-30-2023)
1.013 Billion USD
World Rank (Jan-07-2022)
13,818
Market Cap (Jan-07-2022)
0.474 Billion USD
World Rank (Jan-01-2021)
8,883
Market Cap (Jan-01-2021)
0.806 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
PLRX
Market Cap (Mar-08-2026)
0.08
Employee Count
112
Employee Count as of Date
As on July 2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
10 Million USD
Annual Operating Income in USD
-127 Million USD
Annual Net Income in USD
-123 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
350 Million USD
Total Liabilities in USD
37 Million USD
Total Equity in USD
313 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Biotechnology
Company Website
PLIANT THERAPEUTICS, INC.
Company Profile
Pliant Therapeutics is a Clinical Stage Biopharmaceutical company focused on the developing new treatments for fibrotic diseases. The company estimated annual revenue is currently 18.9 million USD per year. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share